Cargando…

MAGIC: once upon a time in consent management—a FHIR(®) tale

BACKGROUND: The use of medical data for research purposes requires an informed consent of the patient that is compliant with the EU General Data Protection Regulation. In the context of multi-centre research initiatives and a multitude of clinical and epidemiological studies scalable and automatable...

Descripción completa

Detalles Bibliográficos
Autores principales: Bialke, Martin, Bahls, Thomas, Geidel, Lars, Rau, Henriette, Blumentritt, Arne, Pasewald, Sandra, Wolff, Robert, Steinmann, Jonas, Bronsch, Tobias, Bergh, Björn, Tremper, Galina, Lablans, Martin, Ückert, Frank, Lang, Stefan, Idris, Tarik, Hoffmann, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137912/
https://www.ncbi.nlm.nih.gov/pubmed/30217236
http://dx.doi.org/10.1186/s12967-018-1631-3
_version_ 1783355254400614400
author Bialke, Martin
Bahls, Thomas
Geidel, Lars
Rau, Henriette
Blumentritt, Arne
Pasewald, Sandra
Wolff, Robert
Steinmann, Jonas
Bronsch, Tobias
Bergh, Björn
Tremper, Galina
Lablans, Martin
Ückert, Frank
Lang, Stefan
Idris, Tarik
Hoffmann, Wolfgang
author_facet Bialke, Martin
Bahls, Thomas
Geidel, Lars
Rau, Henriette
Blumentritt, Arne
Pasewald, Sandra
Wolff, Robert
Steinmann, Jonas
Bronsch, Tobias
Bergh, Björn
Tremper, Galina
Lablans, Martin
Ückert, Frank
Lang, Stefan
Idris, Tarik
Hoffmann, Wolfgang
author_sort Bialke, Martin
collection PubMed
description BACKGROUND: The use of medical data for research purposes requires an informed consent of the patient that is compliant with the EU General Data Protection Regulation. In the context of multi-centre research initiatives and a multitude of clinical and epidemiological studies scalable and automatable measures for digital consent management are required. Modular form, structure, and contents render a patient’s consent reusable for varying project settings in order to effectively manage and minimise organisational and technical efforts. RESULTS: Within the DFG-funded project “MAGIC” (Grant Number HO 1937/5-1) the digital consent management service tool gICS was enhanced to comply with the recommendations published in the TMF data protection guideline for medical research. In addition, a structured exchange format for modular consent templates considering established standards and formats in the area of digital informed consent management was designed. Using the new FHIR standard and the HAPI FHIR library, the first version for an exchange format and necessary import-/export-functionalities were successfully implemented. CONCLUSIONS: The proposed exchange format is a “work in progress”. It represents a starting point for current discussions concerning digital consent management. It also attempts to improve interoperability between different approaches within the wider IHE-/HL7-/FHIR community. Independent of the exchange format, providing the possibility to export, modify and import templates for consents and withdrawals to be reused in similar clinical and epidemiological studies is an essential precondition for the sustainable operation of digital consent management.
format Online
Article
Text
id pubmed-6137912
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61379122018-09-15 MAGIC: once upon a time in consent management—a FHIR(®) tale Bialke, Martin Bahls, Thomas Geidel, Lars Rau, Henriette Blumentritt, Arne Pasewald, Sandra Wolff, Robert Steinmann, Jonas Bronsch, Tobias Bergh, Björn Tremper, Galina Lablans, Martin Ückert, Frank Lang, Stefan Idris, Tarik Hoffmann, Wolfgang J Transl Med Methodology BACKGROUND: The use of medical data for research purposes requires an informed consent of the patient that is compliant with the EU General Data Protection Regulation. In the context of multi-centre research initiatives and a multitude of clinical and epidemiological studies scalable and automatable measures for digital consent management are required. Modular form, structure, and contents render a patient’s consent reusable for varying project settings in order to effectively manage and minimise organisational and technical efforts. RESULTS: Within the DFG-funded project “MAGIC” (Grant Number HO 1937/5-1) the digital consent management service tool gICS was enhanced to comply with the recommendations published in the TMF data protection guideline for medical research. In addition, a structured exchange format for modular consent templates considering established standards and formats in the area of digital informed consent management was designed. Using the new FHIR standard and the HAPI FHIR library, the first version for an exchange format and necessary import-/export-functionalities were successfully implemented. CONCLUSIONS: The proposed exchange format is a “work in progress”. It represents a starting point for current discussions concerning digital consent management. It also attempts to improve interoperability between different approaches within the wider IHE-/HL7-/FHIR community. Independent of the exchange format, providing the possibility to export, modify and import templates for consents and withdrawals to be reused in similar clinical and epidemiological studies is an essential precondition for the sustainable operation of digital consent management. BioMed Central 2018-09-14 /pmc/articles/PMC6137912/ /pubmed/30217236 http://dx.doi.org/10.1186/s12967-018-1631-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Bialke, Martin
Bahls, Thomas
Geidel, Lars
Rau, Henriette
Blumentritt, Arne
Pasewald, Sandra
Wolff, Robert
Steinmann, Jonas
Bronsch, Tobias
Bergh, Björn
Tremper, Galina
Lablans, Martin
Ückert, Frank
Lang, Stefan
Idris, Tarik
Hoffmann, Wolfgang
MAGIC: once upon a time in consent management—a FHIR(®) tale
title MAGIC: once upon a time in consent management—a FHIR(®) tale
title_full MAGIC: once upon a time in consent management—a FHIR(®) tale
title_fullStr MAGIC: once upon a time in consent management—a FHIR(®) tale
title_full_unstemmed MAGIC: once upon a time in consent management—a FHIR(®) tale
title_short MAGIC: once upon a time in consent management—a FHIR(®) tale
title_sort magic: once upon a time in consent management—a fhir(®) tale
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137912/
https://www.ncbi.nlm.nih.gov/pubmed/30217236
http://dx.doi.org/10.1186/s12967-018-1631-3
work_keys_str_mv AT bialkemartin magiconceuponatimeinconsentmanagementafhirtale
AT bahlsthomas magiconceuponatimeinconsentmanagementafhirtale
AT geidellars magiconceuponatimeinconsentmanagementafhirtale
AT rauhenriette magiconceuponatimeinconsentmanagementafhirtale
AT blumentrittarne magiconceuponatimeinconsentmanagementafhirtale
AT pasewaldsandra magiconceuponatimeinconsentmanagementafhirtale
AT wolffrobert magiconceuponatimeinconsentmanagementafhirtale
AT steinmannjonas magiconceuponatimeinconsentmanagementafhirtale
AT bronschtobias magiconceuponatimeinconsentmanagementafhirtale
AT berghbjorn magiconceuponatimeinconsentmanagementafhirtale
AT trempergalina magiconceuponatimeinconsentmanagementafhirtale
AT lablansmartin magiconceuponatimeinconsentmanagementafhirtale
AT uckertfrank magiconceuponatimeinconsentmanagementafhirtale
AT langstefan magiconceuponatimeinconsentmanagementafhirtale
AT idristarik magiconceuponatimeinconsentmanagementafhirtale
AT hoffmannwolfgang magiconceuponatimeinconsentmanagementafhirtale